Mechanism of neuroprotective effect induced by QingKaiLing as an adjuvant drug in rabbits with E. coli bacterial meningitis

Acta Neurochirurgica, Supplementum

Volumn , Issue 96, 2006, Pages 413-418

  Yue, S ^a   Li, Q ^a   Liu, S ^a   Luo, Z ^a   Tang, F ^a   Feng, D ^a   Yu, P ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

adjuvant therapy; bacterial meningitis; brain damage; Escherichia coli; QingKaiLing

Indexed keywords

ANTIINFECTIVE AGENT; HERBACEOUS AGENT; NEUROPROTECTIVE AGENT;

ACUTE DISEASE; ADJUVANT CHEMOTHERAPY; ANIMAL; ARTICLE; BACTERIAL MENINGITIS; DRUG COMBINATION; ENCEPHALITIS; RABBIT; TREATMENT OUTCOME;

ACUTE DISEASE; ANIMALS; ANTI-BACTERIAL AGENTS; CHEMOTHERAPY, ADJUVANT; DRUG COMBINATIONS; DRUGS, CHINESE HERBAL; ENCEPHALITIS; MENINGITIS, ESCHERICHIA COLI; NEUROPROTECTIVE AGENTS; RABBITS; TREATMENT OUTCOME;

EID: 85052610172     PISSN: 00651419     EISSN: None     Source Type: Book Series    
DOI: 10.1007/3-211-30714-1_85     Document Type: Article

References (16)

1. Atkinson JJ, Senior RM (2003) Matrix metalloproteinase-9 in lung remodeling. Am J Respir Cell Mol Biol 28:12-24
2. Chaudhuri A (2004) Adjunctive dexamethasone treatment in acute bacterial meningitis. Lancet Neurol 3:54-62
3. Ko SY, Shim JW, Kim SS, Kim MJ, Chang YS, Park WS, Shin SM, Lee MH (2003) Effects of MK-801 (dizocilpine) on brain cell membrane function and energy metabolism in experimental Escherichia coli meningitis in the newborn piglet. J Korean Med Sci 18:236-241
4. Koedel U, Scheld WM, Pfister HW (2002) Pathogenesis and pathophysiology of pneumococcal meningitis. Lancet Infect Dis 2:721-736
5. Lee KY, Kim EH, Yang WS, Ryu H, Cho SN, Lee BI, Heo JH (2004) Persistent increase of matrix metalloproteinases in cerebrospinal fluid of tuberculous meningitis. J Neurol Sci 220:73-78
6. Leppert D, Leib SL, Grygar C, Miller KM, Schaad UB, Holländer GA (2000) Matrix metalloproteinase (MMP)-8 and MMP-9 in cerebrospinal fluid during bacterial meningitis: association with blood-brain barrier damage and neurological sequelae. Clin Infect Dis 31:80-84
7. Liu YX (1993) Effects of anisodamine and ampicillin on cerebrospinal fluid in experimental E. coli meningitis. Zhonghua Yi Xue Za Zhi 73:289-291 [in Chinese]
8. Meli DN, Christen S, Leib SL (2003) Matrix metalloproteimase-9 in pneumococcal meningitis: activation via an oxidative pathway. J Infect Dis 187:1411-1415
9. Meli DN, Loeffler JM, Baumann P, Neumann U, Buhl T, Leppert D, Leib SL (2004) In pneumococcal meningitis a novel water-soluble inhibitor of matrix metalloproteinases and TNF-alpha converting enzyme attenuates seizures and injury of the cerebral cortex. J Neuroimmunol 151:6-11
10. Song A, Zhu W (2003) The protective effect of Qingkailin on forebrain neuron in intracranial hemorrhage in rat. J Baot Med Coll 19:8-10
11. Southan GJ, Szabo C (1996) Selective pharmacological inhibition of distinct nitric oxide synthase isoforms. Biochem Pharmacol 51:383-394
12. Sun F (2001) Therapeutic effect of Qinkailing injection on serum cytokine in chronic obstructive pulmonary disease. Pharmacol Clin Chin Mat Med 11:37-41
13. Tao Y, Yue S, Yu Y, Yang Y (2000) Effect of Qingkailin on free calcium of synaptosomes in rats with neurotoxic brain edema induced by L-glutamate. Chin J Contemp Pediatr 2:326-328
14. Yang J, Cheng H (2001) Advance of QingKaiLing injection in clinic application and its pharmacology. Chin Hosp Pharm J 21:494-497
15. Yue S, Luo Z, Yu P, Deng S, Xia L (1998) The protective effect of Qingkailin on neurotoxic brain edema induced by glutamate. J Beijing Univ TCM 21:32-33
16. Yue S, Zeng Q, Zhou J, Tao Y, Zeng S, Wu G, Yu P, Luo Z (2000) Experimental study of protective effect of Qingkailing on glutamate induced neurotoxic damage of brain. Chin J Integrate Tradition West Med 20:842-845